John de Koning is a Partner at EQT Life Sciences, one of Europe's largest healthcare investment firms, where they focus on innovative life sciences and health care companies. They have served on the boards of several organizations, including Tenpoint Therapeutics, Merus, and eTheRNA Immunotherapies. John has an extensive background in board membership with companies like argenx and VarmX. Currently, John is pursuing a PhD in Oncology at the Erasmus Medical Center Rotterdam, along with a Post Doctoral Fellowship at UCSF and an MSc in Medical Biology from the University of Utrecht.
This person is not in the org chart
This person is not in any offices